The present and future burden of previously treated advanced non-small cell lung cancer (NSCLC) by histology and line of therapy in France, Germany, Italy, and Spain: model-based predictions

• Egile Nagusiak: David Campbell (Egilea), Ken O'Day (Egilea), Nadine Hertel (Egilea), John R. Penrod (Egilea), Melinda Manley Daumont (Egilea), Michael Lees (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2018-11-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background The burden of advanced non-small cell lung cancer (NSCLC) is not well understood, and the number of patients likely to receive treatment in Europe has not been quantified. The aim of this study was to forecast the annual number of patients with squamous and non-squamous advanced...